×

Controlled release compositions for treatment of cognitive, emotional and mental ailments and disorders

  • US 9,149,472 B2
  • Filed: 11/04/2013
  • Issued: 10/06/2015
  • Est. Priority Date: 08/31/2004
  • Status: Active Grant
First Claim
Patent Images

1. A method for improving cognitive function comprising:

  • selecting a patient, andadministering to the patient montelukast sodium in a solid dosage form, the solid dosage form comprising a therapeutically effective amount of montelukast sodium, wherein the amount of montelukast sodium is greater than about 20 mg, anda rate release modifier, wherein the rate release modifier provides the patient a controlled release of montelukast sodium for at least about 4 hours.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×